Journal of Clinical Oncology | 2024
Post-Transplant Cyclophosphamide based Graft-versus-Host Disease Prophylaxis Eliminates Disparities in Outcomes Between Matched and Mismatched Unrelated Donor Hematopoietic Cell Transplantation.
Shaffer BC, Gooptu M, DeFor TE, Maiers M, Bolaños-Meade J, Abboud R, Briggs AD, Khimani F, Modi D, Newcomb R, Shpall EJ, Bupp C, Spellman SR, Stefanski HE, Shaw BE, Auletta JJ, Devine SM, Jimenez Jimenez AM, Al Malki MM
PubMed
PMID: 39018507
Abstract
Related Articles
CIBMTR Study #: CIBMTR_NA